Eran Broshy

Directeur/Membre du Conseil chez CERTARA, INC. Fortune : 1 M $ au 30/06/2026

Profil

Eran Broshy currently works at Thirty Madison, Inc., as Chairman from 2022, American Friends of The Open University of Israel, as Chairman, Simon Wiesenthal Center, Inc., as Director from 2010, Theravance Biopharma, Inc., as Independent Director from 2014, Certara, Inc., as Independent Director from 2022, Massachusetts Institute of Technology, as Member, The American Jewish Committee, as Member-Governors Board, and MIT Corp.
(United States), as Member.
Mr. Broshy also formerly worked at Coelacanth Corp., as President & Chief Executive Officer from 1998 to 1999, Ventiv Health, Inc., as Chairman from 2008 to 2010, inVentiv Health, Inc., as Chairman in 2010, ERT Operating Co., as Chairman, ERT Operating Co., as Chairman, Neurogen Corp., as Director from 2003 to 2009, Magellan Health, Inc., as Independent Director from 2009 to 2019, Virtual Radiologic Corp., as Director, Union Street Acquisition Corp., as Director from 2006 to 2008, Visiant Holdings, Inc., as Director, HeartFlow, Inc., as Director, Correlagen Diagnostics, Inc., as Director, Israel Venture Network, as Director, Tailwind Capital LLC, as Director from 2015 to 2021, Nordic Capital Corp., as Director from 2016 to 2021, Dermarite Holdings LLC, as President, Director & Manager, The Boston Consulting Group, Inc., as Managing Partner from 1984 to 1998, Providence Equity Partners LLC, as Senior Advisor, Linden Manager LLC, as Operating Partner from 2010 to 2015, and Court Square Capital Management LP, as Operating Partner from 2013 to 2015.
Mr. Broshy received his graduate degree from Stanford University, undergraduate degree from Massachusetts Institute of Technology, and Masters Business Admin degree from Harvard Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
THERAVANCE BIOPHARMA INC 0,09 %	13/04/2026	44 703 ( 0,09 % )	759 951 $	30/06/2026
CERTARA, INC. 0,03 %	14/05/2026	50 708 ( 0,03 % )	332 137 $	30/06/2026

Postes actifs de Eran Broshy

Sociétés	Poste	Début
THERAVANCE BIOPHARMA, INC.	Directeur/Membre du Conseil	02/06/2014
CERTARA, INC.	Directeur/Membre du Conseil	11/07/2022
MIT Corp. (United States)	Corporate Officer/Principal	-
Thirty Madison, Inc.	Président	01/11/2022
American Friends of The Open University of Israel	Président	-
The American Jewish Committee	Directeur/Membre du Conseil	-
Massachusetts Institute of Technology	Corporate Officer/Principal	-
Simon Wiesenthal Center, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Eran Broshy

Sociétés	Poste	Fin
Nordic Capital Corp.	Directeur/Membre du Conseil	01/12/2021
░░░░░░░░ ░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░